Latest Insider Transactions at International Flavors & Fragrances Inc (IFF)
This section provides a real-time view of insider transactions for International Flavors & Fragrances Inc (IFF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTERNATIONAL FLAVORS & FRAGRANCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTERNATIONAL FLAVORS & FRAGRANCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,241
+45.23%
|
-
|
|
Dec 30
2021
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
3,481
+45.49%
|
$400,315
$115.48 P/Share
|
|
Sep 15
2021
|
Winder Investment Pte LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
979,000
+3.75%
|
$139,997,000
$143.75 P/Share
|
|
May 14
2021
|
Ilene S Gordon Director |
BUY
Open market or private purchase
|
Direct |
1,000
+44.35%
|
$140,000
$140.39 P/Share
|
|
May 13
2021
|
Simon Herriott Pres. Health & Bioscience |
SELL
Open market or private sale
|
Direct |
1,332
-46.8%
|
$183,816
$138.47 P/Share
|
|
May 13
2021
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
1,513
+34.71%
|
$173,995
$115.48 P/Share
|
|
May 06
2021
|
Carol Anthony Davidson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
255
+50.0%
|
-
|
|
May 06
2021
|
Ilene S Gordon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
255
+50.0%
|
-
|
|
May 06
2021
|
Kathryn Jean Boor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
255
+50.0%
|
-
|
|
May 06
2021
|
Matthias Heinzel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
255
+50.0%
|
-
|
|
May 06
2021
|
Edward D Breen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
255
+35.92%
|
-
|
|
May 06
2021
|
Kare Schultz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
255
+50.0%
|
-
|
|
May 06
2021
|
Christina A Gold Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,047
+13.28%
|
-
|
|
May 05
2021
|
Rustom Jilla CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,198
+27.67%
|
$316,512
$144.67 P/Share
|
|
Apr 05
2021
|
Gonzalez Susana Suarez EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,176
-7.21%
|
$163,464
$139.0 P/Share
|
|
Apr 05
2021
|
Robert G. Anderson Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
582
-3.68%
|
$80,898
$139.0 P/Share
|
|
Apr 05
2021
|
Francisco Fortanet EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,635
-6.34%
|
$227,265
$139.0 P/Share
|
|
Apr 05
2021
|
Andreas Fibig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,407
-10.81%
|
$1,307,573
$139.0 P/Share
|
|
Apr 05
2021
|
Nicolas Mirzayantz President, Nourish |
SELL
Payment of exercise price or tax liability
|
Direct |
1,600
-4.28%
|
$222,400
$139.0 P/Share
|
|
Apr 02
2021
|
Gonzalez Susana Suarez EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,569
+13.97%
|
-
|
|
Apr 02
2021
|
Robert G. Anderson Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,713
+9.77%
|
-
|
|
Apr 02
2021
|
Francisco Fortanet EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
4,282
+14.24%
|
-
|
|
Apr 02
2021
|
Andreas Fibig CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,413
+19.75%
|
-
|
|
Apr 02
2021
|
Nicolas Mirzayantz President, Nourish |
BUY
Exercise of conversion of derivative security
|
Direct |
4,710
+11.18%
|
-
|
|
Mar 15
2021
|
Gonzalez Susana Suarez EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
83
-1.4%
|
$11,288
$136.79 P/Share
|
|
Mar 15
2021
|
Gonzalez Susana Suarez EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
181
+2.95%
|
-
|
|
Mar 15
2021
|
Robert G. Anderson Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
40
-0.28%
|
$5,440
$136.79 P/Share
|
|
Mar 15
2021
|
Robert G. Anderson Controller |
BUY
Grant, award, or other acquisition
|
Direct |
120
+0.84%
|
-
|
|
Mar 15
2021
|
Francisco Fortanet EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.34%
|
$10,064
$136.79 P/Share
|
|
Mar 15
2021
|
Francisco Fortanet EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
193
+0.89%
|
-
|
|
Mar 15
2021
|
Nicolas Mirzayantz President, Nourish |
SELL
Payment of exercise price or tax liability
|
Direct |
133
-0.4%
|
$18,088
$136.79 P/Share
|
|
Mar 15
2021
|
Nicolas Mirzayantz President, Nourish |
BUY
Grant, award, or other acquisition
|
Direct |
389
+1.17%
|
-
|
|
Feb 19
2021
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
190
-18.3%
|
$26,410
$139.24 P/Share
|
|
Feb 19
2021
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
616
+37.24%
|
-
|
|
Feb 19
2021
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-28.82%
|
$38,503
$139.24 P/Share
|
|
Feb 19
2021
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
708
+42.42%
|
-
|
|
Feb 19
2021
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-21.74%
|
$26,688
$139.24 P/Share
|
|
Feb 19
2021
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
584
+39.81%
|
-
|
|
Feb 15
2021
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
24
-8.66%
|
$3,264
$136.21 P/Share
|
|
Feb 15
2021
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
58
+17.31%
|
-
|
|
Feb 15
2021
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
27
-8.28%
|
$3,672
$136.21 P/Share
|
|
Feb 15
2021
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
81
+19.9%
|
-
|
|
Feb 15
2021
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
35
-7.66%
|
$4,760
$136.21 P/Share
|
|
Feb 15
2021
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
105
+18.68%
|
-
|
|
Feb 14
2021
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-40.0%
|
$19,856
$136.21 P/Share
|
|
Feb 14
2021
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
365
+50.0%
|
-
|
|
Feb 14
2021
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
120
-32.88%
|
$16,320
$136.21 P/Share
|
|
Feb 14
2021
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
365
+50.0%
|
-
|
|
Feb 14
2021
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
173
-32.95%
|
$23,528
$136.21 P/Share
|
|
Feb 14
2021
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
525
+50.0%
|
-
|